Metraipolis › archive › dc_3802ae3e8d8a
USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation — Europe PMC PMID:41882191
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41882191
- DOI
- 10.1038/s44319-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T21:43:50.709Z
- SHA-256 of the archived text
5b708c15ff1034980a9d88a0ba063dde951e1a6015df22678838496d9cc50fd6- Stable URL of this page
https://metraipolis.com/documento/dc_3802ae3e8d8a
How to cite
USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation — Europe PMC PMID:41882191 — Europe PMC (en), https://europepmc.org/article/MED/41882191 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3802ae3e8d8a (Metraipolis archive dc_3802ae3e8d8a, sha256 5b708c15ff1034980a9d88a0ba063dde951e1a6015df22678838496d9cc50fd6)
BibTeX
@misc{dc3802ae3e8d8a,
title = {USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation — Europe PMC PMID:41882191},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41882191},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3802ae3e8d8a; sha256 5b708c15ff1034980a9d88a0ba063dde951e1a6015df22678838496d9cc50fd6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41882191. Agents can read the archived copy with the MCP tool read_document.